A case of long - term extracorporeal membrane oxygenation in the treatment of acute respiratory distress syndrome in a patient with COVID-19

E. V Kryukov; Крюков Е. В; V. A Chernetsov; Чернецов В. А; A. E Shestopalov; Шестопалов А. Е; V. V Stets; Стец В. В; A. G Zhuravlev; Журавлев А. Г; V. V Morgachev; Моргачев В. В; D. S Meshcheryakov; Мещеряков Д. С

doi:10.17816/RMMJ82540

A case of long - term extracorporeal membrane oxygenation in the treatment of acute respiratory distress syndrome in a patient with COVID-19

作者: Kryukov E.V¹, Chernetsov V.A¹, Shestopalov A.E¹, Stets V.V¹, Zhuravlev A.G¹, Morgachev V.V¹, Meshcheryakov D.S¹
隶属关系:
1. The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation
期: 卷 342, 编号 1 (2021)
页面: 76-79
栏目: Articles
URL: https://journals.eco-vector.com/0026-9050/article/view/82540
DOI: https://doi.org/10.17816/RMMJ82540
ID: 82540

如何引用文章

全文:

开放存取

##reader.subscriptionAccessGranted##
受限制的访问

订阅存取

详细
全文:
作者简介
参考
补充文件
统计

详细

The most common clinical manifestation of COVID-19 is a bilateral lung disease, with acute respiratory distress syndrome (ARDS) developing in 3-4% of cases. The experience of using extracorporeal membrane oxygenation with the ineffectiveness of mechanical ventilation in the treatment of ARDS in patients with coronavirus infection is insignificant. The article demonstrates a case of long - term (30 days) use of extracorporeal membrane oxygenation in a patient with viral total lung disease, CT-4, severe acute respiratory distress syndrome. The possibility and efficiency of the long - term application of the method are presented. Anticoagulant therapy using low molecular weight heparin (enoxaparin) is adequate, reduces the risk of bleeding, determines the duration and effectiveness of using a membrane oxygenator, and reduces the likelihood of thrombosis of the extracorporeal circuit, and preserves its oxygenating function.

关键词

COVID-19, extracorporeal membrane oxygenation, acute respiratory distress syndrome, COVID-19, viral total lung disease, coagulopathy

全文:

参考

Abrams D., Ferguson N., Brochard L. et al. ECMO for ARDS: from salvage to standard of care? // The Lancet Respiratory Medicine. - 2019. - Vol. 7, N 2. - P. 108-110.
Extracorporeal Life Support Organization, General Guidelines for all ECLS Cases, 2019.
https://sccm.org/SurvivingSepsisCampaign /Guidelines/COVID-19
https://www.eurolso.net/ Guidelines for ECMO in COVID-19
https://www.elso.org/Resources/Guide lines.aspx
Li M., Gu S-Ch., Wu X-C. et al. Extracorporeal membrane oxygenation support in 2019 novel coronavirus disease: indications, timing, and implementation // Chinese Med. J. - 2020. - Vol. 133, N 9. - P. 1115-1117.
Ramanathan K., Antognini D., Combes A. et al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases // Lancet Respir Med. - 2020. - Vol. 8, Iss. 5. - P. 518-526.

补充文件

附件文件

动作

1. JATS XML

下载

用户名
密码
记住我

忘记您的密码?	注册

用户名
密码
记住我

忘记您的密码?	注册

A case of long - term extracorporeal membrane oxygenation in the treatment of acute respiratory distress syndrome in a patient with COVID-19

全文:

详细

关键词

全文:

作者简介

E. Kryukov

V. Chernetsov

A. Shestopalov

V. Stets

A. Zhuravlev

V. Morgachev

D. Meshcheryakov

参考

补充文件